| (Values in U.S. Thousands) | Jan, 2026 | Jan, 2025 | Jan, 2024 | Jan, 2023 | Jan, 2022 |
| Sales | 480,590 | 419,810 | 356,300 | 280,910 | 213,230 |
| Sales Growth | +14.48% | +17.82% | +26.84% | +31.74% | +43.42% |
| Net Income | 2,310 | -58,530 | -136,890 | -176,150 | -118,160 |
| Net Income Growth | +103.95% | +57.24% | +22.29% | -49.08% | -332.98% |
Phreesia Inc (PHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Fiscal Year End Date: 01/31